<DOC>
	<DOCNO>NCT00971906</DOCNO>
	<brief_summary>This present study , randomize , single-blind , dose-ranging , multicenter study , evaluate immunogenicity , safety tolerability two dos adjuvanted not-adjuvanted new swine-origin influenza A/H1N1 virus monovalent subunit vaccine healthy adult elderly subject . A booster dose administer 12 month first vaccination .</brief_summary>
	<brief_title>Immunogenicity , Safety Tolerability Two Doses Adjuvanted Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine Healthy Subjects 18 More Years Age</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Males females 18 year age day enrollment ; 2 . Individuals good health 3 . Individuals able comply study procedures 4 . Willingness allow serum sample store beyond study period , potential additional future test good characterize immune response . 1 . Individual able comprehend follow require study procedure ; 2 . History illness might interfere result study pose additional risk subject due participation study ; 3 . Any serious chronic progressive disease accord judgment investigator 4 . History anaphylaxis , serious vaccine reaction , excipients . 5 . Adjuvanted influenza vaccine document confirm suspected influenza disease within 3 month prior Day 1 ; 6 . Receipt another investigational agent within 4 week prior enrollment , completion safety followup period another study ; unwilling refuse participation another clinical study end study ; 7 . Any vaccine within 4 week prior enrollment plan receive vaccine within 4 week study vaccine ; exception plain seasonal influenza vaccine allow 1 week prior 1 week study vaccination . 8 . Receipt blood , blood product and/or plasma derivative parenteral immunoglobulin preparation past 12 week ; 9 . Axillary temperature ≥ 38°C oral temperature ≥ 38.5°C within 3 day intend study vaccination ; 10 . Known suspected impairment/alteration immune function , example result receipt immunosuppressive therapy within 60 day prior Visit 1 ; 11 . History progressive severe neurological disorder ; 12 . Surgery plan study period Investigator 's opinion would interfere study visit schedule ; 13 . Female childbearing potential , use acceptable contraceptive method least 2 month prior study entry ; 14 . Female pregnant nursing ( breastfeed ) mother females childbearing potential plan use acceptable birth control measure first 3 week vaccination ; 15 . Members research staff relatives .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Pandemic influenza</keyword>
	<keyword>Vaccine</keyword>
</DOC>